Importance: Staphylococcus aureus bacteremia is common and frequently associated with poor outcomes. Evidence indicates that specific care processes are associated with improved outcomes for patients with S aureus bacteremia, including appropriate antibiotic prescribing, use of echocardiography to identify endocarditis, and consultation with infectious diseases (ID) specialists. Whether use of these care processes has increased in routine care for S aureus bacteremia or whether use of these processes has led to large-scale improvements in survival is unknown. Objective: To examine the association of evidence-based care processes in routine care for S aureus bacteremia with mortality. Design, Setting, and Participants: This retrospective observational cohort study examined all patients admitted to Veterans Health Administration (VHA) acute care hospitals who had a first episode of S aureus bacteremia from January 1, 2003, through December 31, 2014. Exposures: Use of appropriate antibiotic therapy, echocardiography, and ID consultation. Main Outcomes and Measures: Thirty-day all-cause mortality. Results: Analyses included 36 868 patients in 124 hospitals (mean [SD] age, 66.4 [12.5] years; 36 036 [97.7%] male), including 19 325 (52.4%) with infection due to methicillin-resistant S aureus and 17 543 (47.6%) with infection due to methicillin-susceptible S aureus. Risk-adjusted mortality decreased from 23.5% (95% CI, 23.3%-23.8%) in 2003 to 18.2% (95% CI, 17.9%-18.5%) in 2014. Rates of appropriate antibiotic prescribing increased from 2467 (66.4%) to 1991 (78.9%), echocardiography from 1256 (33.8%) to 1837 (72.8%), and ID consultation from 1390 (37.4%) to 1717 (68.0%). After adjustment for patient characteristics, cohort year, and other care processes, receipt of care processes was associated with lower mortality, with adjusted odds ratios of 0.74 (95% CI, 0.68-0.79) for appropriate antibiotics, 0.73 (95% CI, 0.68-0.78) for echocardiography, and 0.61 (95% CI, 0.56-0.65) for ID consultation. Mortality decreased progressively as the number of care processes that a patient received increased (adjusted odds ratio for all 3 processes compared with none, 0.33; 95% CI, 0.30-0.36). An estimated 57.3% (95% CI, 48.4%-69.9%) of the decrease in mortality between 2003 and 2014 could be attributed to increased use of these evidence-based care processes. Conclusions and Relevance: Mortality associated with S aureus bacteremia decreased significantly in VHA hospitals, and a substantial portion of the decreasing mortality may have been attributable to increased use of evidence-based care processes. The experience in VHA hospitals demonstrates that increasing application of these care processes may improve survival among patients with S aureus bacteremia in routine health care settings.
Importance: Staphylococcus aureus bacteremia is common and frequently associated with poor outcomes. Evidence indicates that specific care processes are associated with improved outcomes for patients with S aureus bacteremia, including appropriate antibiotic prescribing, use of echocardiography to identify endocarditis, and consultation with infectious diseases (ID) specialists. Whether use of these care processes has increased in routine care for S aureus bacteremia or whether use of these processes has led to large-scale improvements in survival is unknown. Objective: To examine the association of evidence-based care processes in routine care for S aureus bacteremia with mortality. Design, Setting, and Participants: This retrospective observational cohort study examined all patients admitted to Veterans Health Administration (VHA) acute care hospitals who had a first episode of S aureus bacteremia from January 1, 2003, through December 31, 2014. Exposures: Use of appropriate antibiotic therapy, echocardiography, and ID consultation. Main Outcomes and Measures: Thirty-day all-cause mortality. Results: Analyses included 36 868 patients in 124 hospitals (mean [SD] age, 66.4 [12.5] years; 36 036 [97.7%] male), including 19 325 (52.4%) with infection due to methicillin-resistant S aureus and 17 543 (47.6%) with infection due to methicillin-susceptible S aureus. Risk-adjusted mortality decreased from 23.5% (95% CI, 23.3%-23.8%) in 2003 to 18.2% (95% CI, 17.9%-18.5%) in 2014. Rates of appropriate antibiotic prescribing increased from 2467 (66.4%) to 1991 (78.9%), echocardiography from 1256 (33.8%) to 1837 (72.8%), and ID consultation from 1390 (37.4%) to 1717 (68.0%). After adjustment for patient characteristics, cohort year, and other care processes, receipt of care processes was associated with lower mortality, with adjusted odds ratios of 0.74 (95% CI, 0.68-0.79) for appropriate antibiotics, 0.73 (95% CI, 0.68-0.78) for echocardiography, and 0.61 (95% CI, 0.56-0.65) for ID consultation. Mortality decreased progressively as the number of care processes that a patient received increased (adjusted odds ratio for all 3 processes compared with none, 0.33; 95% CI, 0.30-0.36). An estimated 57.3% (95% CI, 48.4%-69.9%) of the decrease in mortality between 2003 and 2014 could be attributed to increased use of these evidence-based care processes. Conclusions and Relevance: Mortality associated with S aureus bacteremia decreased significantly in VHA hospitals, and a substantial portion of the decreasing mortality may have been attributable to increased use of evidence-based care processes. The experience in VHA hospitals demonstrates that increasing application of these care processes may improve survival among patients with S aureus bacteremia in routine health care settings.
Authors: Jennifer S McDanel; Eli N Perencevich; Daniel J Diekema; Loreen A Herwaldt; Tara C Smith; Elizabeth A Chrischilles; Jeffrey D Dawson; Lan Jiang; Michihiko Goto; Marin L Schweizer Journal: Clin Infect Dis Date: 2015-04-21 Impact factor: 9.079
Authors: S Tom; J C Galbraith; L Valiquette; G Jacobsson; P Collignon; H C Schønheyder; M Søgaard; K J Kennedy; J D Knudsen; C Ostergaard; O Lyytikäinen; K B Laupland Journal: Clin Microbiol Infect Date: 2014-02-20 Impact factor: 8.067
Authors: Rajiv Jain; Stephen M Kralovic; Martin E Evans; Meredith Ambrose; Loretta A Simbartl; D Scott Obrosky; Marta L Render; Ron W Freyberg; John A Jernigan; Robert R Muder; LaToya J Miller; Gary A Roselle Journal: N Engl J Med Date: 2011-04-14 Impact factor: 91.245
Authors: Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Imad M Tleyjeh; Michael J Rybak; Bruno Barsic; Peter B Lockhart; Michael H Gewitz; Matthew E Levison; Ann F Bolger; James M Steckelberg; Robert S Baltimore; Anne M Fink; Patrick O'Gara; Kathryn A Taubert Journal: Circulation Date: 2015-09-15 Impact factor: 29.690
Authors: Rasmus V Rasmussen; Ulla Høst; Magnus Arpi; Christian Hassager; Helle K Johansen; Eva Korup; Henrik C Schønheyder; Jens Berning; Sabine Gill; Flemming S Rosenvinge; Vance G Fowler; Jacob E Møller; Robert L Skov; Carsten T Larsen; Thomas F Hansen; Shan Mard; Jesper Smit; Paal S Andersen; Niels E Bruun Journal: Eur J Echocardiogr Date: 2011-06
Authors: Marin L Schweizer; Michael R Eber; Ramanan Laxminarayan; Jon P Furuno; Kyle J Popovich; Bala Hota; Michael A Rubin; Eli N Perencevich Journal: Infect Control Hosp Epidemiol Date: 2011-02 Impact factor: 3.254
Authors: Thomas L Holland; Issam Raad; Helen W Boucher; Deverick J Anderson; Sara E Cosgrove; P Suzanne Aycock; John W Baddley; Anne-Marie Chaftari; Shein-Chung Chow; Vivian H Chu; Manuela Carugati; Paul Cook; G Ralph Corey; Anna Lisa Crowley; Jennifer Daly; Jiezhun Gu; Ray Hachem; James Horton; Timothy C Jenkins; Donald Levine; Jose M Miro; Juan M Pericas; Paul Riska; Zachary Rubin; Mark E Rupp; John Schrank; Matthew Sims; Dannah Wray; Marcus Zervos; Vance G Fowler Journal: JAMA Date: 2018-09-25 Impact factor: 56.272
Authors: George S Heriot; Steven Y C Tong; Allen C Cheng; Irani Thevarajan; Michele R Levinson; Kumar Visvanathan; Danny Liew Journal: Eur J Clin Microbiol Infect Dis Date: 2018-01-22 Impact factor: 3.267
Authors: Payal K Patel; M Todd Greene; Mary A M Rogers; David Ratz; Latoya Kuhn; Jennifer Davis; Sanjay Saint Journal: Am J Infect Control Date: 2018-03-13 Impact factor: 2.918
Authors: Marin L Schweizer; Kelly Richardson; Mary S Vaughan Sarrazin; Michihiko Goto; Daniel J Livorsi; Rajeshwari Nair; Bruce Alexander; Brice F Beck; Michael P Jones; Mireia Puig-Asensio; Daniel Suh; Madeline Ohl; Eli N Perencevich Journal: Clin Infect Dis Date: 2021-01-29 Impact factor: 9.079
Authors: Carlos Mejia-Chew; Jane A O'Halloran; Margaret A Olsen; Dustin Stwalley; Ryan Kronen; Charlotte Lin; Ana S Salazar; Lindsey Larson; Kevin Hsueh; William G Powderly; Andrej Spec Journal: Lancet Infect Dis Date: 2019-09-24 Impact factor: 25.071